Salem Investment Counselors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $102K | Hold |
|
|||||
|
2025
Q2 | $91.2K | Hold |
|
|||||
|
2025
Q1 | $91.9K | Buy |
|
|||||
|
2024
Q4 | $63.2K | Sell |
|
|||||
|
2024
Q3 | $77.1K | Sell |
|
|||||
|
2024
Q2 | $78.1K | Hold |
|
|||||
|
2024
Q1 | $86.9K | Buy |
|
|||||
|
2023
Q4 | $72.1K | Buy |
|
|||||
|
2023
Q3 | $69.1K | Hold |
|
|||||
|
2023
Q2 | $68K | Hold |
|
|||||
|
2023
Q1 | $67.8K | Sell |
|
|||||
|
2022
Q4 | $78.6K | Sell |
|
|||||
|
2022
Q3 | $149K | Sell |
|
|||||
|
2022
Q2 | $287K | Buy |
|
|||||
|
2022
Q1 | $256K | Hold |
|
|||||
|
2021
Q4 | $259K | Sell |
|
|||||
|
2021
Q3 | $232K | Buy |
|
|||||
|
2021
Q2 | $234K | Hold |
|
|||||
|
2021
Q1 | $210K | Hold |
|
|||||
|
2020
Q4 | $216K | Sell |
|
|||||
|
2020
Q3 | $225K | Buy |
|
|||||
|
2020
Q2 | $236K | Hold |
|
|||||
|
2020
Q1 | $219K | Hold |
|
|||||
|
2019
Q4 | $272K | Hold |
|
|||||
|
2019
Q3 | $247K | Hold |
|
|||||
|
2019
Q2 | $231K | Sell |
|
|||||
|
2019
Q1 | $244K | Buy |
|
|||||
|
2018
Q4 | $221K | Sell |
|
|||||
|
2018
Q3 | $244K | Hold |
|
|||||
|
2018
Q2 | $245K | Hold |
|
|||||
|
2018
Q1 | $237K | Sell |
|
|||||
|
2017
Q4 | $219K | Buy |
|
|||||
|
2017
Q3 | $249K | Hold |
|
|||||
|
2017
Q2 | $262K | Hold |
|
|||||
|
2017
Q1 | $255K | Sell |
|
|||||
|
2016
Q4 | $259K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $264K | Hold |
|
|||||
|
2016
Q1 | $247K | Hold |
|
|||||
|
2015
Q4 | $246K | Hold |
|
|||||
|
2015
Q3 | $232K | Hold |
|
|||||
|
2015
Q2 | $254K | Hold |
|
|||||
|
2015
Q1 | $281K | Hold |
|
|||||
|
2014
Q4 | $261K | Sell |
|
|||||
|
2014
Q3 | $345K | Hold |
|
|||||
|
2014
Q2 | $401K | Sell |
|
|||||
|
2014
Q1 | $1.49M | Hold |
|
|||||
|
2013
Q4 | $1.49M | Hold |
|
|||||
|
2013
Q3 | $1.4M | Sell |
|
|||||
|
2013
Q2 | $1.61M | Buy |
|